SCHEMBL8778240

SCHEMBL8778240

O=P(O)(O)C(C1CCNCC1S)P(=O)(O)O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.33
ERAP2 Q6P179 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778330 0.80 ANPEP (0.33) ANPEPERAP2
SCHEMBL8778286 0.70 FDPS (0.46) ANPEPERAP2
SCHEMBL8778348 0.70 ANPEP (0.33) ANPEPERAP2
SCHEMBL20016771 0.70 KCNH2 (0.30)
SCHEMBL9082333 0.67 ANPEP (0.42) ANPEPERAP2
SCHEMBL9281415 0.66 SLC6A1 (0.33) ANPEPERAP2
SCHEMBL9082645 0.65 CPN1 (0.46) ANPEPERAP2
SCHEMBL8778332 0.64 KDM4E (0.31)
SCHEMBL8778141 0.62 FDPS (0.44)
SCHEMBL9174133 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0648120-B1 USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS PROCTER & GAMBLE PHARMA (US) 1997-12-29 EP disclosed
EP-0648120-A1 USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1995-04-19 EP disclosed
WO-1994000129-A1 USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1994-01-06 WO disclosed